[Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment].
Cobo-Ibáñez
Tatiana
T
Muñoz-Fernández
Santiago
S
Hidalgo-Barrero
Ventura
V
Martín-Mola
Emilio
E
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha; D014605:Uveitis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008727:Methotrexate